Tranexamic acid (topical): Investigated in clinical trials for melasma with more robust evidence than IV glutathione
FDA Disclaimer These statements have not been evaluated by the Food and Drug Administration
This is particularly significant for patients with premature ovarian failure, as oxidative stress is a critical factor contributing to ovarian dysfunction
Leukotriene receptors as potential therapeutic targets
PubMed laboratory research record [PMID: 27411820] PubMed record related to this compound for laboratory literature review
Over time, with regular use, be it in supplement form, skincare products, or IV treatments, you may notice fewer dark spots, less sun damage, and a more uniform tone